H Ring-Larsen Selected Research

Ornipressin

1/2006

Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Ring-Larsen Research Topics

Disease

2	Body Weight (Weight, Body) 06/2010 - 07/2002
1	Hepatorenal Syndrome 01/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2006
1	Chronic Hepatitis C 07/2002
1	Infections 07/2002
1	Viremia 07/2002
1	Fibrosis (Cirrhosis) 01/2001
1	Ascites 01/2001

Drug/Important Bio-Agent (IBA)

1	Ribavirin (Virazole)FDA LinkGeneric 06/2010
1	InterferonsIBA 06/2010
1	Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA 01/2006
1	Vasoconstrictor AgentsIBA 01/2006
1	TerlipressinIBA 01/2006
1	Midodrine (Midon)FDA LinkGeneric 01/2006
1	OrnipressinIBA 01/2006
1	Alanine (L-Alanine)FDA Link 07/2002
1	Transaminases (Aminotransferases)IBA 07/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2002
1	Interferon-alpha (Interferon Alfa)IBA 07/2002
1	Interferon alpha-2 (Roferon-A)FDA Link 07/2002
1	DiureticsIBA 01/2001
1	AlbuminsIBA 01/2001

Therapy/Procedure

2	Therapeutics 01/2006 - 07/2002
1	Liver Transplantation 01/2006